Schiff base-forming compounds inhibit estrogen receptor-positive and -negative mammary carcinoma cell proliferation.

被引：0
|
作者：
Davis, BA [1 ]
机构：
[1] Virginia Polytech Inst & State Univ, Mol Nutr Lab, Blacksburg, VA 24061 USA
来源：
FASEB JOURNAL | 2001年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A963 / A963
页数：1
相关论文
共 50 条
  • [41] Genetic polymorphisms of transforming growth factor-beta1 and estrogen metabolizing enzyme in estrogen receptor-positive and -negative infiltrating ductal breast carcinoma
    Babyshkina, N.
    Malinovskaya, E.
    Ivanova, A.
    Cherdyntseva, N.
    Slonimskaya, E.
    Gulyaeva, L.
    EJC SUPPLEMENTS, 2010, 8 (07): : 197 - 197
  • [42] DIFFERENTIAL DISTRIBUTION OF ACTIVITIES OF PROTEIN PHOSPHATASES 2A AND 2C IN ESTROGEN RECEPTOR-POSITIVE AND RECEPTOR-NEGATIVE BREAST-CARCINOMA CELL-LINES
    CHEN, ZH
    GUNDIMEDA, U
    YOOLEE, K
    GOPALAKRISHNA, R
    FASEB JOURNAL, 1994, 8 (04): : A397 - A397
  • [43] CHARACTERIZATION AND QUANTITATION OF ANTI-ESTROGEN BINDING-SITES IN ESTROGEN RECEPTOR-POSITIVE AND RECEPTOR-NEGATIVE HUMAN-BREAST CANCER CELL-LINES
    MILLER, MA
    KATZENELLENBOGEN, BS
    CANCER RESEARCH, 1983, 43 (07) : 3094 - 3100
  • [44] Inhibition of cell proliferation by 17β-estradiol and heregulin β1 in estrogen receptor negative human breast carcinoma cell lines
    Yoo, JY
    Lessor, T
    Hamburger, AW
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 51 (01) : 71 - 81
  • [45] Inhibition of cell proliferation by 17β-estradiol and heregulin β1 in estrogen receptor negative human breast carcinoma cell lines
    Joo-Yeon Yoo
    Tracy Lessor
    Anne W. Hamburger
    Breast Cancer Research and Treatment, 1998, 51 : 71 - 81
  • [46] Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer
    Wahdan-Alaswad, Reema S.
    Edgerton, Susan M.
    Kim, Hyun Min
    Tan, Aik Choon
    Haugen, Bryan R.
    Liu, Bolin
    Thor, Ann D.
    CELL CYCLE, 2023,
  • [47] Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell lines
    Ellis, CA
    Vos, MD
    Wickline, M
    Riley, C
    Vallecorsa, T
    Telford, WG
    Zujewski, J
    Clark, GJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (01) : 59 - 67
  • [48] SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer
    Ando, Yuki
    Masuda, Takaaki
    Hayashi, Naoki
    Kosai, Keisuke
    Shibuta, Shohei
    Ono, Yuya
    Taro, Tobo
    Otsu, Hajime
    Hisamatsu, Yuichi
    Yoshizumi, Tomoharu
    Mimori, Koshi
    BREAST CANCER, 2025, : 457 - 469
  • [49] Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines
    Chad A. Ellis
    Michele D. Vos
    Meredith Wickline
    Christine Riley
    Teresa Vallecorsa
    William G. Telford
    JoAnne Zujewski
    Geoffrey J. Clark
    Breast Cancer Research and Treatment, 2003, 78 : 59 - 67
  • [50] New cellular effects of clodronate: stimulation of estrogen receptor-positive breast cancer cell proliferation in steroid-free medium
    Journe, F
    Chaboteaux, C
    Laurent, G
    Dumon, JC
    Body, JJ
    BONE, 2004, 34 : S59 - S59
12345